MedWatch

Analyst comments on Novo Nordisk's record-breaking stock price

On Tuesday, Novo Nordisk’s stock price has passed a milestone, which could indicate that investors are hoping for a guidance upgrade later this year, Sydbank Analyst Søren Løntoft Hansen says.

Photo: Novo Nordisk / PR

A run of positive news of a smaller size is why Novo Nordisk’s stock price has increased so much that it broke its previous record on Tuesday, assesses Senior Equity Analyst at Sydbank Søren Løntoft Hansen.

During the day, the Novo stock went up by 1.5 percent at DKK 779 (USD 114.9), passing the company’s previous record of DKK 770.4 (USD 113.6), which was set on Dec. 16 when trading closed.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs